Indian Journal of Respiratory Care

IJRC Email      Register      Login

VOLUME 13 , ISSUE 3 ( July-September, 2024 ) > List of Articles

Original Article

Profile of Nonresolving Pneumonia in a Tertiary Care Center in South India: A Prospective Study

Narendra K Narahari, Rakesh Kodati, Devanandan Korambatta, Shantveer G Uppin, Anu Kapoor, Bhaskar Kakarla, Paramjyothi Gongati

Keywords : Flexible bronchoscopy, Invasive fungal disease, Nonresolving pneumonia, Tuberculosis

Citation Information : Narahari NK, Kodati R, Korambatta D, Uppin SG, Kapoor A, Kakarla B, Gongati P. Profile of Nonresolving Pneumonia in a Tertiary Care Center in South India: A Prospective Study. Indian J Respir Care 2024; 13 (3):163-171.

DOI: 10.5005/jp-journals-11010-1125

License: CC BY-NC 4.0

Published Online: 30-09-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Introduction: Nonresolving pneumonia (NRP) or slowly resolving pneumonia is a major concern among clinicians. The definition and approach toward diagnosis and management are unclear. Herein, we conducted a prospective observational study to analyze the comorbidities, etiology, and mode of diagnosis of NRP at our center. Methodology: All subjects admitted with a diagnosis of NRP (who received at least 2 weeks of antimicrobial therapy without any clinical improvement) were enrolled in the study. Patients with poor general condition, hemodynamic instability, and uncooperative patients were excluded from the study. After noting clinical and demographic details, contrast-enhanced computed tomography (CT) scan was done for all patients. All subjects were assessed to undergo flexible bronchoscopy, image-guided sampling, surgical lung biopsy, or pleural fluid analysis based on the imaging findings on CT scan. The details of the mode of diagnosis and the yield of procedures were noted. Results: We included 102 subjects; an infective etiology was diagnosed in 64 (62.7%) of the cases and 38 (37.2%) were diagnosed to be of noninfective etiology. Among the infections, pulmonary tuberculosis [21 (20.6%)] and invasive fungal diseases [20 (19.5%)] were the most common diagnoses. Diabetes mellitus (57.8%) and recent COVID-19 (26.5%) were the common comorbid conditions predisposing to infection. Among the noninfectious etiology, pulmonary adenocarcinoma was the most common diagnosis seen in 14 (13.7%) cases. Flexible bronchoscopy was most instrumental in obtaining the diagnosis as seen in 71 (69.6%) cases, followed by image-guided biopsy in 17 (16.6%) and surgical lung biopsy in 7 (6.9%) patients. Overall yield of bronchoscopy in our study population is 77.2% (71/92) and image-guided sampling is 94.4% (17/18). The infectious group had shorter disease duration, more comorbid illnesses, mucopurulent secretions on bronchoscopy, and higher mortality at 1 month as compared to noninfectious group. After adjusting the covariates, the presence of fever [odds ratio (OR) 12.75; 95% confidence interval (CI), 2.74–59.26] and recent history of COVID-19 (OR 12.29; 95% CI, 1.43–105.6) were independently associated with infectious etiology. Conclusion: Infections, particularly tuberculosis and invasive fungal diseases, are the major causes of NRP. Diabetes mellitus is the predominant underlying comorbid illness, and recent infection with COVID-19 is an emerging risk factor for NRP. Flexible bronchoscopy and image-guided sampling, when used in rational approach, are helpful in establishing the diagnosis of NRP.


PDF Share
  1. Weyers CM, Leeper KV. Nonresolving pneumonia. Clin Chest Med 2005;26(1):143–158. DOI: 10.1016/j.ccm.2004.10.011
  2. Kirtland SH, Winterbauer RH. Slowly resolving, chronic, and recurrent pneumonia. Clin Chest Med 1991;12(2):303–318. DOI: 10.1016/S0272-5231(21)00745-0
  3. Menéndez R, Perpiñá M, Torres A. Evaluation of nonresolving and progressive pneumonia. Semin Respir Infect 2003;18(2):103–111.
  4. Gotway MB, Leung JWT, Dawn SK, et al. Nonresolving pneumonia in an otherwise healthy patient. Clin Pulm Med 2004;11(3):198–200. DOI: 10.1097/01.cpm.0000127380.44405.bd
  5. Duarte JC, Cordeiro CR, Ferreira AJ. Role of flexible bronchoscopy in non-resolving community-acquired pneumonia—a retrospective analysis. Rev Port Pneumol (2006) 2017;23(3):168–169. DOI: 10.1016/j.rppnen.2017.01.009
  6. Ruiz M, Ewig S, Marcos MA, et al. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am J Respir Crit Care Med 1999;160(2):397–405. DOI: 10.1164/ajrccm.160.2.9808045
  7. Arancibia F, Ewig S, Martinez JA, et al. Antimicrobial treatment failures in patients with community-acquired pneumonia: causes and prognostic implications. Am J Respir Crit Care Med 2000;162(1):154–160. DOI: 10.1164/ajrccm.162.1.9907023
  8. Black AD. Non-infectious mimics of community-acquired pneumonia. Pneumonia (Nathan) 2016;8:2. DOI: 10.1186/s41479-016-0002-1
  9. Fein AM. Pneumonia in the elderly: overview of diagnostic and therapeutic approaches. Clin Infect Dis 1999;28(4):726–729. DOI: 10.1086/515218
  10. Chaudhuri AD, Mukherjee S, Nandi S, et al. A study on non-resolving pneumonia with special reference to role of fiberoptic bronchoscopy. Lung India 2013;30(1):27–32. DOI: 10.4103/0970-2113.106130
  11. Casqueiro J, Casqueiro J, Alves C. Infections in patients with diabetes mellitus: a review of pathogenesis. Indian J Endocrinol Metab 2012;16(Suppl 1):S27–S36. DOI: 10.4103/2230-8210.94253
  12. Kodati R, Narahari NK, Tadepalli A, et al. A young boy with diabetic ketoacidosis and non-resolving pneumonia. Breathe (Sheff) 2023;19(4):230161. DOI: 10.1183/20734735.0161-2023
  13. Muthu V, Agarwal R, Rudramurthy SM, et al. Risk factors, mortality, and predictors of survival in COVID-19-associated pulmonary mucormycosis: a multicentre retrospective study from India. Clin Microbiol Infect 2024;30(3):368–374. DOI: 10.1016/j.cmi.2023.12.006
  14. Morton CO, Griffiths JS, Loeffler J, et al. Defective antifungal immunity in patients with COVID-19. Front Immunol 2022;13:1080822. DOI: 10.3389/fimmu.2022.1080822
  15. Feinsilver SH, Fein AM, Niederman MS, et al. Utility of fiberoptic bronchoscopy in nonresolving pneumonia. Chest 1990;98(6):1322–1326. DOI: 10.1378/chest.98.6.1322
  16. Gandara DR, Aberle D, Lau D, et al. Radiographic imaging of bronchioloalveolar carcinoma: screening, patterns of presentation and response assessment. J Thorac Oncol 2006;1(9 Suppl.):S20–S26. DOI: 10.1016/S1556-0864(15)30005-8
  17. Ramesh PM, Saravanan M. A clinical study on non-resolving pneumonia in tertiary care centre. Int J Adv Med 2018;5(3):604. DOI: 10.18203/2349-3933.ijam20182110
  18. Pasha MM, Vinod K, Salimath SS, et al. Evaluation of diagnostic outcomes of non-resolving pneumonia by fiberoptic bronchoscopy. IP Indian J Immunol Respir Med 2020;3(2):56–60. DOI: 10.18231/2581-4222.2018.0016
  19. Dey P, Deb J, Biswas S, et al. Diagnostic role of bronchoscopy in non-resolving pneumonia. Int J Dent Med Sci Res 2021;3(6):83–90. DOI: 10.35629/5252-03068390
  20. Jayaprakash B, Varkey V, Anithakumari K. Etiology and clinical outcome of non-resolving pneumonia in a tertiary care centre. J Assoc Physicians India 2012;60:98–101.
  21. Chathamparamb B, Antony A, Ullas Nivarthil S, et al. Non-resolving pneumonia aetiology and clinical profile: a prospective study. J Evol Med Dent Sci 2016;5(19):954–958. DOI: 10.14260/jemds/2016/222
  22. Mishra GP, Ghorpade SV, Balakrishnan RK. Role of fiberoptic bronchoscopy in non-resolving pneumonia. Natl J Med Res 2016;6(4):316–320.
  23. Madhavi KVP, Praveena S, Praveen JV, et al. Role of fiberoptic bronchoscopy in early diagnosis of non-resolving pneumonia. Panacea J Med Sci 2023;13(2):423–426. DOI: 10.18231/j.pjms.2023.080
  24. Vineela S, Bhagyaraj A, Laxmi YS, et al. A study on non-resolving pneumonia: role of fiberoptic bronchoscopy and CT-guided biopsy. J Evid Based Med Healthc 2019;6(35):2397–2401. DOI: 10.18410/jebmh/2019/490
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.